Related Experiment Video
Updated: May 21, 2026
06:48
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
Spectroscopic and molecular docking studies on chlorambucil interaction with DNA
Sonika Charak1, Manish Shandilya, Gunjan Tyagi
1Quantum Optics and Photon Physics, National Physical Laboratory-Council of Scientific and Industrial Research, Dr. K.S. Krishnan Road, New Delhi 110012, India.
International Journal of Biological Macromolecules
|June 20, 2012
Summary
Chlorambucil (CMB) weakly binds DNA through nitrogenous bases, maintaining DNA
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- Chlorambucil (CMB) is a crucial anticancer drug.
- Understanding its molecular mechanism of action is vital for cancer therapy.
Purpose of the Study:
- To investigate the interaction between Chlorambucil and DNA at a molecular level.
- To determine the binding site, binding constant, and conformational effects of CMB on DNA.
Main Methods:
- Spectroscopic techniques including FTIR, UV-visible, and CD spectroscopy.
- Molecular docking studies were performed to analyze CMB-DNA interactions.
Main Results:
- Chlorambucil binds to DNA via nitrogenous bases (thymine, guanine, cytosine).
- A weak binding constant (1.3 × 10³ M⁻¹) was determined.
- CMB does not alter the native B-conformation of DNA.
Conclusions:
- CMB interacts with DNA through its nitrogenous bases.
- The drug exhibits weak binding affinity to the DNA double helix.
- CMB preserves the B-conformation of DNA, indicating a non-disruptive binding mechanism.
